A two pager of what you need to know of Sofosbuvir

A two pager of what you need to know of Sofosbuvir

Bangkok 11 August 2015

TREAT Asia just published an overview documentation on Sofosbuvir, the snapshot provides a brief summary of the medication, its regulatory approvals, treatment response data from early clinical trials and pricing information.

Click here to see the full document

/ News

Related Posts

Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
Read More
Story from Ajitshwor Wangkheirakpam, Manipur, India
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Letter from Asian community and treatment advocates to Chief Executive Officer of CHAI regarding the Quick start program and concerns that patients would have to pay for sofosbuvir and diagnostics to be a part of the program in October 2016
IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
Part 1: What is hepatitis C and how is it diagnosed?
Hepatitis C Treatment Snapshots: Daclatasvir
Flawed patents on hepatitis C drugs latest to be challenged in global push for access